Vol 5 Issue 3

CELL AND GENE THERAPY INSIGHTS

Vol 5 Issue 3

Cell and Gene Therapy Insights Vol 5 Issue 3

Download PDF

Featuring

Issue Spotlight: Upstream Bioprocessing Update
Cold Chain Management
Other articles
Webinar

Upstream Bioprocessing Update

Editorial

Manufacturing of genetically modified autologous T cells: key considerations for process development

Manufacturing of genetically modified autologous T cells: key considerations for process development

Mamta Kalra, Ali Mohamed

Expert Insight

Bioprocessing & biological challenges of large-scale red blood cell production from pluripotent stem cells: important factors to consider

Bioprocessing & biological challenges of large-scale red blood cell production from pluripotent stem cells: important factors to consider

Steve Oh, Jaichandran Sivalingam

Commentary

Key success criteria and factors for delivering scalable cell therapy upstream bioprocesses

Key success criteria and factors for delivering scalable cell therapy upstream bioprocesses

Creating a cell-friendly microenvironment to enhance cell culture efficiency

Creating a cell-friendly microenvironment to enhance cell culture efficiency

Ou Wang, Yuguo Lei

Interview

Challenges in upstream bioprocess development for viral vector production

Challenges in upstream bioprocess development for viral vector production

Ankita Desai, Philipp Nold

Determining the optimal culture system for your scale up strategy

Determining the optimal culture system for your scale up strategy

Marco Koppe, Clive Glover

A 3D vision for the future of tissue engineering

A 3D vision for the future of tissue engineering

Suwan N Jayasinghe

Podcast

Determining the optimal culture system for your scale up strategy

Determining the optimal culture system for your scale up strategy

Marco Koppe, Clive Glover

Cold Chain Management

Interview

Overcoming current challenges & limitations with dry shipper technology

Overcoming current challenges & limitations with dry shipper technology

Overcoming Supply Chain Challenges in Cell and Gene Therapies

Overcoming Supply Chain Challenges in Cell and Gene Therapies

Where is cold chain innovation particularly badly needed for a commercializing industry?

Where is cold chain innovation particularly badly needed for a commercializing industry?

Dr Allison Hubel

Journal articles

Interview

Taming the Last Frontier: Harmonizing the Upstream-Downstream Interface

Taming the Last Frontier: Harmonizing the Upstream-Downstream Interface

Commercial Insights

Cell & Gene Therapy Commercial Insight – March 2019

Cell & Gene Therapy Commercial Insight – March 2019

Mark Curtis, Richard Philipson

Using patient outcomes data to inform and advance the development of emerging cell and gene therapies

Using patient outcomes data to inform and advance the development of emerging cell and gene therapies

D Henke, C Wilfong, M Pasquini